Introduction
Cirrhosis of the liver is associated with complications of portal hypertension, such as gastrointestinal bleeding and refractory ascites. The creation of a transjugular intrahepatic portosystemic shunt (TIPS) is now considered an effective therapy in managing such complications.
1 TIPS dysfunction is secondary to acute stent thrombosis, pseudointimal hyperplasia, or intimal hyperplasia in the outflow hepatic vein. [2] [3] [4] A nonfunctioning TIPS is treated either by balloon angioplasty, stent insertion, or creating a parallel shunt (PS). PS is the last therapeutic option when the initial shunt cannot be accessed by a guidewire or percutaneous needle. We report a case of a patient who presented with refractory variceal bleeding 5 years after chronic TIPS occlusion. The patient was successfully treated by creating a parallel TIPS after a failure to recanalize the preexisting TIPS.
Case Report
A 72-year-old man presented to our hospital with massive hematemesis. He was known to have hepatic cirrhosis for over 11 years. He had undergone TIPS creation 9 years prior to the presentation due to recurrent variceal bleeding despite endoscopic therapy. Five years prior to the presentation, he had a history of massive hematemesis. Endoscopy and duplex ultrasound at that time revealed grade 3 esophageal varices and an occluded TIPS, respectively. The measured hepatic venous pressure gradient was 23 mm Hg and TIPS revision was unsuccessful. He was managed conservatively with endoscopic and medical therapy. On examination, the patient had splenomegaly and ascites. Laboratory values included hemoglobin of 6.7 g/dL, white cell count of 8,000/cubic mL, and platelets of 20,000/cubic mL. The total bilirubin was 3.2 mg/dL, creatinine 1.6 mg/dL, and international normalized ratio 1.4. The measured Model of End-Stage Liver Disease score at the time of presentation was 19. Due to continued variceal bleeding, the patient underwent TIPS recanalization procedure through a transjugular access. This procedure was unsuccessful due to the chronicity of occluded TIPS. Percutaneous recanalization of the shunt was considered risky due to the presence of severe thrombocytopenia and ascites. A decision was made to create a parallel
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Transjugular intrahepatic portosystemic shun (TIPS) dysfunction is usually secondary to acute thrombosis within the stent, pseudointimal hyperplasia in the TIPS parenchymal tract, or intimal hyperplasia in the outflow hepatic vein. Several methods have been used in treating TIPS dysfunction, including balloon angioplasty, stent insertion, and the creation of a parallel TIPS. We report a case of refractory variceal bleeding in which a parallel TIPS was successfully created after failure to recanalize the preexisting occluded TIPS. 
Discussion
TIPS is now considered an effective therapy in managing complications of portal hypertension. [5] [6] [7] [8] [9] It is recommended that patients with TIPS are followed regularly by periodic duplex examination of the shunt. Secondary interventions may be required to maintain patency of the shunt. TIPS dysfunction can be secondary to acute stent thrombosis, hepatic venous outflow neointimal hyperplasia, and pseudointimal hyperplasia within the stentgraft. 4 TIPS stent extending up to the hepatic vein ostium is associated with better long-term patency of TIPS than that terminating within the hepatic vein.
9
An occluded or dysfunctional TIPS is treated based on the etiology of the occlusion. It is usually accessed through a transjugular venous access. Acute thrombosis is treated with pharmacological or mechanical thrombolysis followed by balloon angioplasty or stent extension, depending on the underlying pathology that resulted in acute thrombosis. Chronic stenosis or occlusion is treated with balloon angioplasty; however, many require repeat stenting. A percutaneous transhepatic or transplenic access to treat an occluded TIPS is reported and is applied when the transjugular route is unsuccessful. These alternative accesses are associated with high risk of bleeding especially in the presence of thrombocytopenia. If the existent shunt could not be recanalized, then a PS may be created to reduce portal pressure. In a series of 29 patients with PS placement, Dabos et al 10 described that the PS patency was slightly superior to the patency of the preexisting TIPS. In another series of 40 patients, Helmy et al 11 described that the natural history of PSs as opposed to the non-PSs after a follow-up of 11.6 months was similar.
In conclusion, PS creation with covered stent grafts, though technically challenging, is a safe and efficacious method in the management of refractory variceal bleeding and unsalvageable, preexisting TIPS dysfunction.
